Pharma manufacturer uses 340B Vigilance to prevent duplicate discounts
Pharma manufacturer uses 340B Vigilance to prevent duplicate discounts
2 PagesA leading pharmaceutical manufacturer participating in the 340B Drug Pricing Program faced challenges such as limited visibility into prescriptions dispensed using 340B inventory, manual efforts to identify duplicate rebate claims, and revenue loss due to duplicate discounts. With Model N's Validata and 340B Vigilance, the company automated prescription validation, preventing over $50 million in rebate overpayments in the first year. The solution improves rebate accuracy across managed care, Medicare, Medicaid, TRICARE, and coverage gaps, while also preventing duplicate discounts and streamlining data management.
